secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2024-11-04T23:59:59+00:00
Accession:  0001217234-24-000101
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx Q3 revenue $82.9M (+23% YoY), raises FY guidance to $327-331M with positive EBITDA $6.9M
--------------------------------------------------------------------------------

- Revenue $82.9M (+23% YoY); testing services rev $60.8M (+27%); volume 44,600 tests (+16%).
- GAAP net loss $7.4M improved from -$23.5M; non-GAAP net income $8.0M; positive adjusted EBITDA $6.9M.
- Raised FY2024 revenue guidance to $327-331M (from $320-328M) and adjusted EBITDA to $18-22M (from $9-15M).
- DOJ concluded investigation with no finding of wrongdoing; CMS reaffirmed coverage for AlloSure/AlloMap.
- Cash $241M, no debt; hired new COO, CCO, and Chief Data/AI Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723424000101/0001217234-24-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723424000101/cdna-20241104.htm
  HTML page:      https://secwatch.observer/filing/0001217234-24-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer